Records containing: NAFLD
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-03-10Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian Multicenter National Study
-
CLINICAL_TRIALS study record update · 2022-03-04Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus Obtained Via a Non-invasive Screening Protocol
-
CLINICAL_TRIALS study record update · 2022-02-25A Randomised Controlled Pilot Study to Test the Role of Medium- and Long-chain Triacylglycerols (MLCT) in Reversing the Phenotype of Non-alcoholic Steatohepatitis (NASH) Patients
-
CLINICAL_TRIALS study record update · 2022-01-28Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2022-01-13Characterization of the Platelet Inflammatory Response in NAFL and NASH
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-01-04EUS Guided Liver Biopsy Proposal Titled : EUS Guided Liver Biopsy - Will it Give Better Yield , More Tissue With Less Complication ?
-
CLINICAL_TRIALS study record update · 2021-12-29A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adults With NASH and T2DM
-
CLINICAL_TRIALS study record update · 2021-12-23Weight Loss Effects of Mobile Health Application in Obesity Multidisciplinary Outpatient
-
CLINICAL_TRIALS study record update · 2021-12-09Diets Based on PNPLA3 Genotype for Reducing Liver Fat in Hispanics With Pediatric Non-alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2021-11-02Evaluation of Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease Patients
-
CLINICAL_TRIALS study record update · 2021-11-02Assessment of Chronic Kidney Disease in Non Alcoholic Fatty Liver Disease(NAFLD) Patients
-
CLINICAL_TRIALS study record update · 2021-10-07Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery
-
CLINICAL_TRIALS study record update · 2021-09-27A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study to Explore the Efficacy and Safety of Elobixibat in Adults With Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2021-09-23A Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Physiological Effects on Liver Structure and Function of an Amino Acid Food Product, AXA1957, in Adolescent Subjects With Fatty Liver
-
CLINICAL_TRIALS study record update · 2021-07-21A Phase 1, Randomized, Placebo-controlled, Double-blind, Two-part Study to Evaluate the Safety and Tolerability of NGM395 in Adult Obese Patients (Part 1) and in Adult Patients With Nonalcoholic Fatty Liver Disease (NAFLD) (Part 2).
-
CLINICAL_TRIALS study record update · 2021-07-02A 16-Week, Single-Blind Randomized, Placebo- Controlled Food Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2021-06-14Identification of Clinical and Biological Factors Determining Disease Severity and Disease Progression in NAFLD: "THE FRENCH NATIONAL NAFLD COHORT" FRAMES (FRench pAtients With MEtabolic Steatosis)
-
CLINICAL_TRIALS study record update · 2021-06-01A Phase 2A Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2021-05-18Prevalence of NASH in Subjects With Different Classes of Obesity
-
CLINICAL_TRIALS study record update · 2021-04-26A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess The Efficacy, Safety, and Tolerability of VK2809 Administered for 12 Weeks Followed by a 4-Week Off-Drug Phase in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2021-04-26Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents
-
CLINICAL_TRIALS study record update · 2021-03-10Use of Shear Wave Elastography in Adolescents and Children With Obesity to Assess Non-alcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2021-03-05The Effects of Plant Stanol Ester Supplements on Liver Inflammation in Overweight and Obese Children
-
CLINICAL_TRIALS study record update · 2021-02-16he Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation and Oxidative Stress Parameters and Faecal Microbiota in Patients With Depression Depending on Metabolic Syndrome Comorbidity
-
CLINICAL_TRIALS study record update · 2021-02-10Copeptin and Nonalcoholic Fatty Liver Disease